No bird soars in a calm: therapeutic germline gene editing.

Therapeutic germline gene editing could shift medicine from treatment to prevention by correcting disease mutations at the embryo stage.

• Why it matters: Inherited diseases impose a significant financial burden on global healthcare systems, highlighting the need for preventive strategies.
• What they did: The study discusses recent advances in precision genome editing and growing public support, indicating readiness for new clinical and regulatory pathways.
• The result: This approach has the potential to transform healthcare by enabling genetic correction before disease manifestation, reducing long-term treatment costs and improving outcomes.